Filter
531
Filtered Results: 531
Text search:
biontech
Featured
Recommendations
65
New Publications
76
Language
Document type
No document type
159
Studies & Reports
127
Guidelines
108
Fact sheets
56
Manuals
38
Strategic & Response Plan
16
Training Material
7
Infographics
6
Resource Platforms
5
Situation Updates
4
Online Courses
3
Brochures
1
Videos
1
Countries / Regions
India
43
Global
22
Germany
19
Brazil
13
South Africa
11
Russia
11
Nepal
10
Ukraine
10
Latin America and the Carribbean
9
Argentina
9
Mozambique
8
Middle East and North Africa
7
Africa
6
Rwanda
5
Bangladesh
5
Nigeria
4
Tanzania
4
West and Central Africa
4
Western and Central Europe
4
Paraguay
4
Zambia
4
Colombia
3
Kenya
3
China
3
Chile
3
Cameroon
3
South–East Asia Region
3
East and Southern Africa
3
Ethiopia
3
Ecuador
3
Myanmar / Burma
3
Thailand
2
Syria
2
Peru
2
Malawi
2
Zimbabwe
2
Philippines
2
USA
2
Asia
2
Spain
2
Vietnam
2
Uganda
2
Namibia
2
Angola
2
Botswana
2
South Sudan
2
El Salvador
1
Turkey
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Iran
1
Senegal
1
Afghanistan
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
France
1
United Kingdom
1
Portugal
1
Belarus
1
Papua New Guinea
1
Sudan
1
Yemen
1
Central African Republic
1
Libya
1
Iraq
1
Somalia
1
Liberia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
200
Clinical Guidelines
33
Pharmacy & Technologies
21
Key Resources
20
Women & Child Health
8
Public Health
6
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
COVID-19
179
AMR
32
NTDs
27
Rapid Response
23
TB
23
Planetary Health
22
HIV
18
Pharmacy
17
Refugee
16
Ebola & Marburg
12
Health Financing Toolbox
11
Global Health Education
7
Social Ethics
6
Caregiver
6
Mental Health
5
Cholera
5
Conflict
5
NCDs
4
Specific Hazards
3
Disability
2
Malaria
1
Zika
1
Polio
1
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
Original text from 2008, updated in 2012. This document marks the beginning of a structured approach to safety assessment of GE foods, which are yet to be approved in our country. It is understood that many changes will become necessary and will be incorporated as we progress. This document will ho...
As of December 2018, CEPI has secured more than USD $747million towards its USD $1billion funding target, with financial support provided by the Bill & Melinda Gates Foundation, the Wellcome Trust, the European Commission, and the governments of Australia, Belgium, Canada, Germany, Japan, Norway, an...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
F.No. INDO/FRC/442/2008-IHD | INDIAN COUNCIL OF MEDICAL RESEARCH
| New Delhi, the 1st July, 2014 | OFFICE MEMORANDUM
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
Презентация на тему диагностики туберкулеза
Countries who have no testing capacity can send their samples to the WHO appointed 2019-nCoV referral laboratories for testing. National 2019-nCoV laboratories with limited experience are encouraged to send the first five positives and the first ten negative 2019-nCoV samples to their referral labor...
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y ...
